AdaptHealth Corp

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AdaptHealth Corp reports robust revenue growth and strategic investments outlook

AdaptHealth Corp demonstrated resilience in revenue growth despite challenges, with a strong focus on patient care and financial performance. While facing short-term obstacles, the company is strategically positioned to capitalize on growth opportunities and improve margins through cost-cutting measures.

AdaptHealth Corp reports revenue growth amidst diabetes business challenges

AdaptHealth Corp's Q1 2023 performance showed revenue growth but faced challenges in the diabetes business, prompting cost-saving measures.
Despite hurdles, the company remains confident in its strategy, focusing on growth opportunities and operational efficiency to drive performance.
Management's proactive approach to cost reduction and revenue enhancement positions AdaptHealth well for future growth and financial stability.

AdaptHealth Corp posts solid Q2 results, eyes growth opportunities

AdaptHealth Corp's Q2 performance reflects strong revenue growth and improved EBITDA, driven by key product lines.
While challenges exist in the diabetes segment, the company is focused on operational enhancements and cost-saving measures.
Opportunities for growth and efficiency improvements are present, with a commitment to executing strategies and leveraging expertise.
Management's emphasis on financial processes and operational efficiency bodes well for future performance and market positioning.

AdaptHealth Corp reports record revenues, faces EBITDA challenges, eyes growth

AdaptHealth Corp's Q3 performance reflects revenue growth driven by the sleep business, with a focus on enhancing patient experience. Challenges include EBITDA shortfall due to contract delays and impairment to goodwill. The company is seizing opportunities in CGM data utilization and diversification strategies for growth.
With a strong emphasis on patient care and operational efficiency, AdaptHealth Corp is navigating challenges in revenue decline and tough comps, aiming for sustained growth. The company's strategic focus on market penetration and patient outcomes positions them for future success.

AdaptHealth Corp excels in Q4 2023, eyes growth opportunities

AdaptHealth Corp's strong performance in Q4 2023 and full-year highlights organic growth.
Challenges from GLP-1 drugs and government exposure are being addressed proactively.
Opportunities lie in projected revenue growth, market share improvement, and cost reduction.
Overall, AdaptHealth is well-positioned for continued growth and market resilience.

AdaptHealth Corp excels in Q1 2024, eyes growth and debt reduction

AdaptHealth Corp's Q1 2024 performance reflects solid financial growth, operational improvements, and strategic initiatives aimed at enhancing profitability and market position.
While challenges like managing potential risks in key segments and addressing debt obligations exist, the company's strengths in leadership, revenue diversification, and cost management provide a strong foundation for future success.
By capitalizing on growth opportunities in key business segments and markets, AdaptHealth Corp is well-positioned to achieve its financial targets, drive sustainable growth, and enhance shareholder value.

AdaptHealth Corp reports solid Q2 results and raises full-year guidance

AdaptHealth Corp's Q2 performance met expectations with a strong focus on driving growth through investments and operational improvements. Despite challenges in certain revenue segments, the company remains optimistic about future prospects.

AdaptHealth Corp reports solid Q3 performance amid operational enhancements

AdaptHealth Corp's Q3 results reflect resilience and strategic initiatives to drive growth amidst operational challenges.
The company's proactive measures to address issues in the diabetes segment and optimize other product lines position it for future success.
With a strengthened financial position and a focus on operational efficiency, AdaptHealth is poised for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Stifel 2024 Healthcare Conference, being held in New York, NY, on Tuesday, November 19, 2024, including a fireside chat at 8:00am ET. The webcast link will be available on the Company's webs.

AdaptHealth Corp. to Participate in the Stifel 2024 Healthcare Conference

AdaptHealth Corp. AHCO reported worse-than-expected third-quarter sales and revised its FY24 net revenue guidance on Tuesday.

These Analysts Lower Their Forecasts On AdaptHealth Following Weak Sales

The company posted a triple whiff, coming in under pundit projections for revenue, profitability, and top-line guidance.

Why AdaptHealth Stock Got Thrashed on Tuesday

AdaptHealth Corp. (NASDAQ:AHCO ) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Suzanne Foster - Chief Executive Officer Jason Clemens - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Mathew Blackman - Stifel Eric Coldwell - Baird Brian Tanquilut - Jefferies Whit Mayo - Leerink Partners Richard Close - Canaccord Pito Chickering - Deutsche Bank Ben Hendrix - RBC Capital Markets Operator Good day, everyone, and welcome to today's AdaptHealth Third Quarter 2024 Earnings Release. [Operator Instructions] Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.

AdaptHealth Corp. (AHCO) Q3 2024 Earnings Call Transcript

AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.19 per share a year ago.

AdaptHealth Corp. (AHCO) Surpasses Q3 Earnings Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quarter ended September 30, 2024. Third Quarter Results and Highlights All comparisons are to the quarter ended September 30, 2023 unless otherwise stated. Net revenue was $805.9 million compa.

AdaptHealth Corp. Announces Third Quarter 2024 Results

Lonza Group AG

Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Lonza Group Ag (LZAGY). But which of these two stocks is more attractive to value investors?

AHCO or LZAGY: Which Is the Better Value Stock Right Now?

Here is how AdaptHealth Corp. (AHCO) and BellRing Brands (BRBR) have performed compared to their sector so far this year.

Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing AdaptHealth (AHCO) Right Now?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. “We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology s.

AdaptHealth Appoints Diana Nole to Board of Directors

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2024 financial results before the opening of the financial markets on Tuesday, November 5, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analys.

AdaptHealth Corp. Announces Third Quarter 2024 Earnings Release Date and Conference Call

Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Lonza Group Ag (LZAGY). But which of these two companies is the best option for those looking for undervalued stocks?

AHCO vs. LZAGY: Which Stock Is the Better Value Option?

Is AdaptHealth (AHCO) Stock Undervalued Right Now?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it has closed a $950 million senior secured credit facility, consisting of a fully funded $650 million Term Loan A (the “Term Loan”), and a $300 million revolving line of credit (the “Revolver”). Proceeds from the new $.

AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity and Reduced Cost of Debt

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Baird Global Healthcare Conference, being held in New York, on Tuesday, September 10, 2024, including a fireside chat at 12:15pm ET. About AdaptHealth Corp. AdaptHealth is a national leader.

AdaptHealth Corp. to Participate in the Baird 2024 Global Healthcare Conference

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Scott Barnhart has been appointed as Chief Operating Officer, effective September 23, 2024. Mr. Barnhart has more than 30 years of leadership experience in global operations including supply chain management, manufactur.

AdaptHealth Corp. Announces New Chief Operating Officer

AHCO shares are down 20% since my last report and are trading at ~10x trailing earnings. Economic characteristics continue to be a drag on corporate performance, likely justifying these multiples. Without an extensive runway to deploy capital and grow earnings, my view is the business is worth ~$11-$12/share today.

AdaptHealth: Continued Divergence In Economic Performance, Reiterate Hold

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Canaccord Genuity 44th Annual Growth Conference, being held in Boston, on Wednesday, August 14, 2024, including a fireside chat presentation at 1:30 pm ET. The webcast link will be available.

AdaptHealth Corp. to Participate in the Canaccord Genuity 44th Annual Growth Conference

AdaptHealth Corporation (NASDAQ:AHCO ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Suzanne Foster - Chief Executive Officer Jason Clemens - Chief Financial Officer Conference Call Participants Jack Slevin - Jefferies Richard Close - Canaccord Genuity Eric Coldwell - Baird Kieran Ryan - Deutsche Bank Joanna Gajuk - Bank of America Operator Good day everyone, and welcome to today's AdaptHealth Second Quarter of 2024 Earnings Release. At this time all participants are in a listen-only mode.

AdaptHealth Corporation (AHCO) Q2 2024 Earnings Call Transcript

AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.16 per share a year ago.

AdaptHealth Corp. (AHCO) Beats Q2 Earnings and Revenue Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2024. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2023 unless otherwise stated. Net revenue was $806.0 million compared to $.

AdaptHealth Corp. Announces Second Quarter 2024 Results

NEW YORK, NY / ACCESSWIRE / July 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (NASDAQ: AHCO). The settlement provides for a fund of $52,000,000 to benefit class members.

Time Sensitive - Reminder from Levi & Korsinsky, LLP to File Claim for Share of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (AHCO) Settlement Fund Before Deadline

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2024 financial results before the opening of the financial markets on Tuesday, August 6, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analyst.

AdaptHealth Corp. Announces Second Quarter 2024 Earnings Release Date and Conference Call

NEW YORK, NY / ACCESSWIRE / July 9, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (NASDAQ: AHCO). The settlement provides for a fund of $52,000,000 to benefit class members.

Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (AHCO) on Upcoming Claims Deadline in a Class Action Settlement

Prestige Brands Holdings

Investors interested in stocks from the Medical - Products sector have probably already heard of AdaptHealth Corp. (AHCO) and Prestige Consumer Healthcare (PBH). But which of these two stocks is more attractive to value investors?

News for AdaptHealth Corp Stock (AHCO)